Dergiler / İstanbul Kuzey Klinikleri / 2020 / Cilt: 7 - Sayı: 4

Successful management with bisphosphonate treatment in a child with tuberculosis-associated hypercalcemia

Sayfa
411–414
Yayın Tarihi
2022-10-18
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Increased 1,25(OH)2D3 synthesis by activated macrophages in the granulomatissue is the major mechanism of hypercalcemia in tuberculosis.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Hypercalcemia is a common metabolic abnormality in children and generally occurs due to hyperparathyroidism, vitamin Dtoxicity, some genetic disorders and malignant diseases.
📊
Temel Bulgular & Veri:Granulomatous diseases are a rare cause of hypercalcemia in children, which are usually mild and asymptomatic.
💡
Sonuç & Katkı:Increased 1,25(OH)2D3 synthesis by activated macrophages in the granulomatissue is the major mechanism of hypercalcemia in tuberculosis.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

Hypercalcemia is a common metabolic abnormality in children and generally occurs due to hyperparathyroidism, vitamin Dtoxicity, some genetic disorders and malignant diseases. Granulomatous diseases are a rare cause of hypercalcemia in children, which are usually mild and asymptomatic. Severe hypercalcemia in granulomatous diseases has also been reported inthe literature. Here, we report a child presenting with severe hypercalcemia secondary to miliary tuberculosis with successfulmanagement with bisphosphonate treatment. Increased 1,25(OH)2D3 synthesis by activated macrophages in the granulomatissue is the major mechanism of hypercalcemia in tuberculosis.

🔖

Bu Makaleye Atıf Yap

KILINÇ, S., EROL, M., BOSTAN, Ö., ERTÜRK, S., YİĞİT, Ö., DİLEK, D. (2022). Successful management with bisphosphonate treatment in a child with tuberculosis-associated hypercalcemia. İstanbul Kuzey Klinikleri, Cilt: 7 - Sayı: 4, 411–414. https://ajindex.com/articles/551390

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (14)

  1. Tebben PJ, Singh RJ, Kumar R. Vitamin D-Mediated Hypercalcemia: Mechanisms, Diagnosis, and Treatment. Endocr Rev 2016;37:521–47
  2. Payne HA, Menson E, Sharland M, Bryant PA. Symptomatic hypercalcaemia in paediatric tuberculosis. Eur Respir Rev 2011;20:53–6
  3. Chan TY, Chan CH, Shek CC. The prevalence of hypercalcaemia in pulmonary and miliary tuberculosis--a longitudinal study. Singapore Med J 1994;35:613–5
  4. Ayonrinde OT, Zimmerman MJ. Ascites, hypercalcaemia, diffuse peritoneal thickening and elevated OM-MA in a fifteen-year-old girl (a case of peritoneal tuberculosis). Intern Med J 2004;34:216–7
  5. Gaskin KJ, Vines RH. Hypercalcaemia: an unusual complication of tuberculosis. A case report. Aust Paediatr J 1978;14:44–7
  6. Gerritsen J, Knol K. Hypercalcaemia in a child with miliary tuberculosis. Eur J Pediatr 1989;148:650–1
  7. Okascharoen C, Nuntnarumit P, Sirinavin S. Neonatal tuberculosis associated with shock, disseminated intravascular coagulation, hemophagocytic syndrome, and hypercalcemia: a case report. J Perinatol 2003;23:79–81
  8. Saggese G, Bertelloni S, Baroncelli GI, Di Nero G. Ketoconazole decreases the serum ionized calcium and 1,25-dihydroxyvitamin D levels in tuberculosis-associated hypercalcemia. Am J Dis Child 1993;147:270–3
  9. Saggese G, Bertelloni S, Baroncelli GI, Fusaro C, Gualtieri M. Abnormal synthesis of 1,25-dihydroxyvitamin D and hypercalcemia in children with tuberculosis. Pediatr Med Chir 1989;11:529–32
  10. Tresoldi AT, Pereira RM, Castro LC, Rigatto SZ, Belangero VM. Hypercalcemia and multiple osteolytic lesions in a child with disseminated paracoccidioidomycosis and pulmonary tuberculosis. J Pediatr (Rio J) 2005;81:349–52
  11. Demir K, Döneray H, Kara C, Atay Z, Çetinkaya S, Çayır A, et al. Comparison of Treatment Regimens in Management of Severe Hypercalcemia Due to Vitamin D Intoxication in Children. J Clin Res Pediatr Endocrinol 2019;11:140–8
  12. Kara C, Çetinkaya S, Gündüz S, Can Yılmaz G, Aycan Z, Aydın M. Efficacy and safety of pamidronate in children with vitamin D intoxication. Pediatr Int 2016;58:562–8
  13. Cadranel JL, Garabédian M, Milleron B, Guillozzo H, Valeyre D, Paillard F, et al. Vitamin D metabolism by alveolar immune cells in tuberculosis: correlation with calcium metabolism and clinical manifestations. Eur Respir J 1994;7:1103–10
  14. Crowley R, Gittoes N. How to approach hypercalcaemia. Clin Med (Lond) 2013;13:287–90.